Matthew Wood is Professor of Neuroscience at the University of Oxford and Co-Director of the Oxford Centre for Neuromuscular Science. He is also Associate Head (Research) of the Medical Sciences Division of the University of Oxford. Matthew trained in Medicine at the University of Cape Town working in clinical neuroscience before completing a PhD at the University of Oxford. Following an MRC postdoctoral fellowship he was appointed to his current position in 1999.
Matthew is a world-renowned molecular neuroscientist with more than 120 peer-reviewed papers. His principal research interests relate to RNA biology and the development of RNA therapeutics for neuromuscular disease. He was one of the founding members of the UK MDEX Consortium in 2004 and is currently the Co-PI of MDEX. He works closely with major research funding agencies and with DMD charitable foundations including Action Duchenne on whose Scientific Advisory Board he serves. He is committed to the public understanding of science. Matthew believes that it will only be through the efforts of networks exemplified by TREAT-NMD that new therapies for neuromuscular disease will reach patients effectively and he is committed to using his expertise to further the aims of the TREAT-NMD Alliance.